Send feedback

CRYGC p.Cys42Arg

c.124T>C · rs200511472 · VCV3077899

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7199 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0493%, mid)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.7199likely pathogenic
REVEL0.677pathogenic-leaning
SaProtLLR -12.37damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6.5GERP 2.5, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 1,586 bp · p 0.96 · regional, not allelic
Overall
CADD24.2PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0493% Middle Eastern · 3/6,084 alleles
Filtering AF 0.0134% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00715%
Overall 0.00198% 32/1,614,130 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.054% 1,851
Middle Easterngrpmax 0.0493% 2,028
African / African-American 0.00267% 37,469
Admixed American 0.00167% 60,010
Remaining individualsnot grpmax-eligible 0.0016% 62,490
South Asian 0.0011% 91,092
European (non-Finnish) 0.000678% 147,506

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CRYGC
Protein
p.Cys42Arg
Coding
c.124T>C
MANE Select
NM_020989
dbSNP
rs200511472
Type
single nucleotide variant
Location
chr2:208129569 (GRCh38)
Gene constraint
LOEUF 0.941 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 96.66 · 1 PDB
Residue 42
a β-strand; the beta/gamma crystallin 'greek key' 2 domain
Full CRYGC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/crygc-p-cys42arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown